Over 2000-fold increased production of the leaderless bacteriocin garvicin KS by increasing gene dose and optimization of culture conditions

Amar A Telke, Kirill V Ovchinnikov, Kiira Vuoristo, Geir Mathiesen, Tage Torstensen, Dzung B Diep (Corresponding Author)

Research output: Contribution to journalArticleScientificpeer-review

Abstract

The leaderless bacteriocin Garvicin KS (GarKS) is a potent antimicrobial, being active against a wide range of important pathogens. GarKS production by the native producer Lactococcus garvieae KS1546 is, however, relatively low (80 BU/ml) under standard laboratory growth conditions (batch culture in GM17 at 30°C). To improve the production, we systematically evaluated the impact of different media and media components on bacteriocin production. Based on the outcomes, a new medium formulation was made that increased GarKS production about 60-fold compared to that achieved in GM17. The new medium was composed of pasteurized milk and tryptone (PM-T). GarKS production was increased further 4-fold (i.e., to 20,000 BU/ml) by increasing the gene dose of the bacteriocin gene cluster (gak) in the native producer. Finally, a combination of the newly composed medium (PM-T), an increased gene dose and cultivation at a constant pH 6 and a 50–60% dissolved oxygen level in growth medium, gave rise to a GarKS production of 164,000 BU/ml. This high production, which is about 2000-fold higher compared to that initially achieved in GM17, corresponds to a GarKS production of 1.2 g/L. To our knowledge, this is one of the highest bacteriocin production reported hitherto.
Original languageEnglish
Article number389
Pages (from-to)389
Number of pages9
JournalFrontiers in Microbiology
Volume10
DOIs
Publication statusPublished - 5 Mar 2019
MoE publication typeA1 Journal article-refereed

Fingerprint

Bacteriocins
Population Groups
Genes
Milk
Lactococcus
Batch Cell Culture Techniques
Multigene Family
Growth
Oxygen
tryptones

Cite this

Telke, Amar A ; Ovchinnikov, Kirill V ; Vuoristo, Kiira ; Mathiesen, Geir ; Torstensen, Tage ; Diep, Dzung B. / Over 2000-fold increased production of the leaderless bacteriocin garvicin KS by increasing gene dose and optimization of culture conditions. In: Frontiers in Microbiology. 2019 ; Vol. 10. pp. 389.
@article{cdfac11e7eb843f4b5dd5f4419688e4c,
title = "Over 2000-fold increased production of the leaderless bacteriocin garvicin KS by increasing gene dose and optimization of culture conditions",
abstract = "The leaderless bacteriocin Garvicin KS (GarKS) is a potent antimicrobial, being active against a wide range of important pathogens. GarKS production by the native producer Lactococcus garvieae KS1546 is, however, relatively low (80 BU/ml) under standard laboratory growth conditions (batch culture in GM17 at 30°C). To improve the production, we systematically evaluated the impact of different media and media components on bacteriocin production. Based on the outcomes, a new medium formulation was made that increased GarKS production about 60-fold compared to that achieved in GM17. The new medium was composed of pasteurized milk and tryptone (PM-T). GarKS production was increased further 4-fold (i.e., to 20,000 BU/ml) by increasing the gene dose of the bacteriocin gene cluster (gak) in the native producer. Finally, a combination of the newly composed medium (PM-T), an increased gene dose and cultivation at a constant pH 6 and a 50–60{\%} dissolved oxygen level in growth medium, gave rise to a GarKS production of 164,000 BU/ml. This high production, which is about 2000-fold higher compared to that initially achieved in GM17, corresponds to a GarKS production of 1.2 g/L. To our knowledge, this is one of the highest bacteriocin production reported hitherto.",
author = "Telke, {Amar A} and Ovchinnikov, {Kirill V} and Kiira Vuoristo and Geir Mathiesen and Tage Torstensen and Diep, {Dzung B}",
year = "2019",
month = "3",
day = "5",
doi = "10.3389/fmicb.2019.00389",
language = "English",
volume = "10",
pages = "389",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media",

}

Over 2000-fold increased production of the leaderless bacteriocin garvicin KS by increasing gene dose and optimization of culture conditions. / Telke, Amar A ; Ovchinnikov, Kirill V; Vuoristo, Kiira; Mathiesen, Geir; Torstensen, Tage; Diep, Dzung B (Corresponding Author).

In: Frontiers in Microbiology, Vol. 10, 389, 05.03.2019, p. 389.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Over 2000-fold increased production of the leaderless bacteriocin garvicin KS by increasing gene dose and optimization of culture conditions

AU - Telke, Amar A

AU - Ovchinnikov, Kirill V

AU - Vuoristo, Kiira

AU - Mathiesen, Geir

AU - Torstensen, Tage

AU - Diep, Dzung B

PY - 2019/3/5

Y1 - 2019/3/5

N2 - The leaderless bacteriocin Garvicin KS (GarKS) is a potent antimicrobial, being active against a wide range of important pathogens. GarKS production by the native producer Lactococcus garvieae KS1546 is, however, relatively low (80 BU/ml) under standard laboratory growth conditions (batch culture in GM17 at 30°C). To improve the production, we systematically evaluated the impact of different media and media components on bacteriocin production. Based on the outcomes, a new medium formulation was made that increased GarKS production about 60-fold compared to that achieved in GM17. The new medium was composed of pasteurized milk and tryptone (PM-T). GarKS production was increased further 4-fold (i.e., to 20,000 BU/ml) by increasing the gene dose of the bacteriocin gene cluster (gak) in the native producer. Finally, a combination of the newly composed medium (PM-T), an increased gene dose and cultivation at a constant pH 6 and a 50–60% dissolved oxygen level in growth medium, gave rise to a GarKS production of 164,000 BU/ml. This high production, which is about 2000-fold higher compared to that initially achieved in GM17, corresponds to a GarKS production of 1.2 g/L. To our knowledge, this is one of the highest bacteriocin production reported hitherto.

AB - The leaderless bacteriocin Garvicin KS (GarKS) is a potent antimicrobial, being active against a wide range of important pathogens. GarKS production by the native producer Lactococcus garvieae KS1546 is, however, relatively low (80 BU/ml) under standard laboratory growth conditions (batch culture in GM17 at 30°C). To improve the production, we systematically evaluated the impact of different media and media components on bacteriocin production. Based on the outcomes, a new medium formulation was made that increased GarKS production about 60-fold compared to that achieved in GM17. The new medium was composed of pasteurized milk and tryptone (PM-T). GarKS production was increased further 4-fold (i.e., to 20,000 BU/ml) by increasing the gene dose of the bacteriocin gene cluster (gak) in the native producer. Finally, a combination of the newly composed medium (PM-T), an increased gene dose and cultivation at a constant pH 6 and a 50–60% dissolved oxygen level in growth medium, gave rise to a GarKS production of 164,000 BU/ml. This high production, which is about 2000-fold higher compared to that initially achieved in GM17, corresponds to a GarKS production of 1.2 g/L. To our knowledge, this is one of the highest bacteriocin production reported hitherto.

UR - http://www.scopus.com/inward/record.url?scp=85066482146&partnerID=8YFLogxK

U2 - 10.3389/fmicb.2019.00389

DO - 10.3389/fmicb.2019.00389

M3 - Article

C2 - 30891018

VL - 10

SP - 389

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

M1 - 389

ER -